Commodore Capital LP Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$1.4T
Holdings
31
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (31 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRUSMERUS N V | 3,874,182 | $162.9B | 11.94% | |
| 2 | PCVXVAXCYTE INC | 1,625,000 | $133.0B | 9.75% | |
| 3 | NUVLNUVALENT INC | 1,621,600 | $126.9B | 9.30% | |
| 4 | XENEXENON PHARMACEUTICALS INC | 2,740,000 | $107.4B | 7.87% | |
| 5 | ELVNENLIVEN THERAPEUTICS INC | 4,205,000 | $94.6B | 6.93% | |
| 6 | VERAVERA THERAPEUTICS INC | 1,958,600 | $82.8B | 6.07% | |
| 7 | SLNOSOLENO THERAPEUTICS INC | 1,525,000 | $68.5B | 5.02% | |
| 8 | ALKSALKERMES PLC | 2,300,000 | $66.1B | 4.85% | |
| 9 | NRIXNURIX THERAPEUTICS INC | 3,000,000 | $56.5B | 4.14% | |
| 10 | COGTCOGENT BIOSCIENCES INC | 6,881,629 | $53.7B | 3.93% | |
| 11 | SYRESPYRE THERAPEUTICS INC | 1,988,084 | $46.3B | 3.39% | |
| 12 | VRDNVIRIDIAN THERAPEUTICS INC | 2,400,000 | $46.0B | 3.37% | |
| 13 | SRRKSCHOLAR ROCK HLDG CORP | 950,000 | $41.1B | 3.01% | |
| 14 | CNTACENTESSA PHARMACEUTICALS PLC | 2,218,425 | $37.2B | 2.72% | |
| 15 | PHVSPHARVARIS N V | 1,911,433 | $36.6B | 2.69% | |
| 16 | BRD1EURMIND MEDICINE MINDMED INC | 4,308,425 | $30.0B | 2.20% | |
| 17 | ORKAORUKA THERAPEUTICS INC | 1,419,714 | $27.5B | 2.02% | |
| 18 | CRDFCARDIFF ONCOLOGY INC | 5,384,616 | $23.4B | 1.71% | |
| 19 | IKTINHIBIKASE THERAPEUTICS INC | 5,925,000 | $19.3B | 1.41% | |
| 20 | NGNENEUROGENE INC | 800,000 | $18.3B | 1.34% | |
| 21 | DRUGBRIGHT MINDS BIOSCIENCES INC | 500,000 | $18.0B | 1.32% | |
| 22 | ORICORIC PHARMACEUTICALS INC | 2,000,000 | $16.1B | 1.18% | |
| 23 | APGEAPOGEE THERAPEUTICS INC | 290,000 | $13.1B | 0.96% | |
| 24 | ABVXABIVAX SA | 1,284,110 | $9.4B | 0.69% | |
| 25 | —PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7.6B | 0.56% | |
| 26 | HLXCHELIX ACQUISITION CORP II | 500,000 | $5.3B | 0.38% | |
| 27 | CELCCELCUITY INC | 400,000 | $5.2B | 0.38% | |
| 28 | VTGNVISTAGEN THERAPEUTICS INC | 1,575,000 | $4.6B | 0.34% | |
| 29 | AVTXAVALO THERAPEUTICS INC | 483,000 | $3.6B | 0.26% | |
| 30 | THRDTHIRD HARMONIC BIO INC | 237,704 | $2.4B | 0.18% | |
| 31 | NKTXNKARTA INC | 351,848 | $876.1M | 0.06% |